For more than 30 years InterWest has partnered with exceptional entrepreneurs to build winning technology and life sciences companies. With more than 200 years of combined operating and investing experience, our team has raised $2.8 billion, completed more than 70 IPOs, and participated in nearly 60 upside acquisitions.
Please visit www.interwest.com for more information.
NEA provides venture and growth capital to help innovative entrepreneurs and business leaders build transformational, industry-leading companies around the world. The NEA track record includes: $11 billion in committed capital, 650+ funded companies, 165+ IPOs, 265+ Mergers and Acquisitions, and a 30-year track record of success.
Please visit www.nea.com for more information.
Prospect Venture Partners
Prospect is a Palo Alto, California based venture capital firm with over $1 billion of capital under management. The firm is dedicated to investing in outstanding biopharmaceutical and medical device companies. Prospect targets commercially attractive biomedical enterprises with outstanding entrepreneurial management teams, proprietary products, and innovative technologies with the potential for significant investment returns. The firm invests in companies with a wide variety of development and financing requirements including new company incubations, first and second venture financing rounds, and later stage private and public companies with proven business models requiring expansion capital.
Please visit www.prospectventures.com for more information.
PureTech Ventures is avidly committed to creating innovative life science companies. We transform breakthrough technologies into leading edge organizations that tackle major unmet needs. Our team of biotech pioneers, pharmaceutical leaders, innovators and entrepreneurs has deep relationships with academic and industry leaders, enabling us to identify exciting new approaches and guide them to commercial and clinical success.
Please visit www.puretechventures.com for more information.